Home About Login Register Search Archives Announcements

 

Aim and Scope

To provide communication and information exchanging platforms for a broad audience of oncologists, surgeons, medical researchers and professionals working in the field.

Editor-in-Chief

Prof. Dr. Kwong-Kwok Wong
The University of Texas MD Anderson Cancer Center

Indexing and Archiving

Advances in Modern Oncology Research is currently indexed in:

-CAS

  • -CNKI
  • -J-gate
  • -Directory of Open Access Journals (DOAJ)
  • -Google Scholar


AMOR is archived by Portico and the National Library Board of Singapore.

User
Submit Your Manuscript

Downloads

Manuscript Submission Template

ICMJE Conflict of Interest Form

Events

Article Tools
Print this article
Indexing metadata
How to cite item
Finding References
Email this article (Login required)
Email the author (Login required)
Post a Comment (Login required)

Tweets by @AMOR_PiscoMed

Keywords bioinformatics breast cancer breast carcinoma cancer case report chemotherapy cisplatin epidemiology immunotherapy mutation non-small cell lung cancer omics oncology ovarian cancer prostate cancer radiotherapy rectal cancer survival targeted therapy therapy treatment
Home > Vol 2, No 1 (2016) > Abdel-Rahman

Personalized hormonal treatment for prostate cancer: An opportunity for improvement

Abstract - 1293 PDF - 291
Omar Abdel-Rahman

Abstract


Not applicable.

Keywords


Prostate cancer; Abiraterone acetate; Hormonal treatment

Full Text:

PDF

References


Abdel-Rahman O. Combined chemohormonal strategy in hormone-sensitive prostate cancer: A pooled analysis of randomized studies. Clin Genitourin Cancer 2015. doi: 10.1016/j.clgc.2015.12.004.


Parker C, Gillessen S, Heidenreich A, Horwich A. Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015; 26 (suppl 5): v69-v77. doi: 10.1093/annonc/mdv222.


Crawford ED, Stone NN, Evan YY, Koo PJ, Freedland SJ, Slovin SF, Gomella LG, Berger ER, Keane TE, Sieber P, Shore ND, Petrylak DP, Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence (RADAR) Group. Challenges and recommendations for early identifi-cation of metastatic disease in prostate cancer. Urology 2014; 83(3): 664-9. doi: j.urology.2013.10.026.


Antonarakis ES, Lu C, Wang H, Luber B, Nakazawa M, Roeser JC, Chen Y, Mohammad TA, Chen Y, Fedor HL, Lotan TL, Zheng Q, De Marzo AM, Isaacs JT, Isaacs WB, Nadal R, Paller CJ, Denmeade SR, Carducci MA, Eisenberger MA, Luo J. AR-V7 and resistance to enzalutamide and abi-raterone in prostate cancer. N Engl J Med 2014; 371(11): 1028-38. doi: 10.1056/NEJMoa1315815.


Mandelkow R, Brunnert D, Weiss M, Burchardt M, Stope MB. Lysophosphatidic acid receptor isoforms expression in prostate cancer cells is differentially regulated by the CYP17A1 inhibitor abiraterone and depends on the androgen receptor. Adv Mod Oncol Res 2016. doi: 10.18282/amor.v2.i1.83.





DOI: http://dx.doi.org/10.18282/amor.v2.i1.121

Refbacks

  • There are currently no refbacks.

Comments on this article

  • Reduza medidas com Line Shake
    by Liliane Fabres (2018-04-25)
  • O Que é Marketing Digital?
    by Gabriela Moreira (2018-06-15)
  • Muito bom
    by EduardaDomingues Infante (2018-06-19)
  • Muito bom
    by HadassaPeixoto Antunes (2018-06-25)
  • Muito bom
    by CarolineCavalcante Soares (2018-06-28)
  • Muito bom
    by AnaSophiaZanette Barros (2018-07-01)
  • Muito bom
    by BarbaraParaíso Trindade (2018-07-03)
  • Dermaglass valor
    by Ádila Ganzaroli (2018-07-05)
  • Dr. Jairo Bouer
    by IsabellaPaiva Assis (2018-07-05)
  • Miocardiopatia Dilatada: Sintomas, Tratamentos E Causas
    by Bernardo Ribeiro (2018-07-29)
  • Regras De Bagagem Pela Alfândega Podem Confundir Passageiro; Empreenda
    by João Caio Teixeira (2018-08-15)
  • Tilimax Caps Anvisa
    by Alex Rocha (2018-08-31)
  • Eros Power Sucesso
    by Alex Rocha (2018-08-31)
  • Playdance Fit Reclame Aqui
    by Alex Rocha (2018-09-04)
  • Test
    by Aurélio Candal (2018-10-19)
View all comments


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Bookmark and Share
                                       

© 2017 by PiscoMed Publishing Pte Ltd